Lineage Cell Therapeutics, Inc. Quarterly Costs and Expenses in USD from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Lineage Cell Therapeutics, Inc. quarterly Costs and Expenses history and growth rate from Q1 2023 to Q2 2024.
  • Lineage Cell Therapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $7.28M, a 11.8% decline year-over-year.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $7.28M -$974K -11.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.11M -$923K -10.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q2 2023 $8.25M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $9.03M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.